{
Boehringer Ingelheim International GmbH

Companies

}
001122334455554433221100
001122334455554433221100

semaglutides market projected to reach 36.87 billion by 2028

The semaglutides market is projected to grow from $20.54 billion in 2023 to $36.87 billion by 2028, driven by rising diabetes prevalence and increased demand for effective treatments. Key players are innovating with GLP-1 receptor analogues and oral formulations to enhance patient adherence and reduce side effects. North America leads the market, while Asia-Pacific is expected to be the fastest-growing region.
GlobeNewswire News Room
United States Dollar Adocia SA Sanofi SA Eli Lilly and Company Roche Holding AG Pfizer Inc. Merck & Co., Inc. Dr. Reddy's Laboratories Limited Boehringer Ingelheim International GmbH Glaxosmithkline plc Takeda Pharmaceutical Company Limited AbbVie Inc. Novartis International AG Bristol-Myers Squibb Company Novo Nordisk A/S Cipla Limited Biocon Limited Teva Pharmaceutical Industries Ltd AstraZeneca PLC Amgen Inc. ITA IND FRA IDN CAN ESP BRA USA RUS CHN DEU AUS JPN GBR KOR Show more
Healthcare, Market Report
10:12 06.01.2025

Torrent Pharmaceuticals Acquires Three Anti-Diabetes Brands from Boehringer Ingelheim

Torrent Pharmaceuticals is set to acquire three anti-diabetes brands from Boehringer Ingelheim GmbH: Cospiaq (empagliflozin), Cospiaq Met (empagliflozin + metformin), and Xilingio (empagliflozin + linagliptin). The deal, which follows a co-marketing agreement initiated in 2022, is expected to be finalized by March 2025.
Moneycontrol
Boehringer Ingelheim International GmbH Torrent Pharmaceuticals Limited Boehringer Ingelheim India Ltd. IND DEU Show more
Healthcare, Press Release
03:09 05.12.2024

livestock healthcare market poised for significant growth driven by disease prevention and technology

The livestock healthcare market is projected to grow from $50.74 billion in 2023 to $79.39 billion by 2028, driven by rising livestock populations, intensifying farming practices, and increasing awareness of zoonotic diseases. Key trends include technological innovations, biosecurity measures, and a focus on animal welfare. Major players in the market include Merck, Zoetis, and Bayer, among others, as they adapt to evolving disease landscapes and consumer demands.
openPR.com
Alltech Inc. Kemin Industries Inc. IDEXX Laboratories Inc Jurox Pty Ltd. Ceva Santé Animale Intas Pharmaceuticals Ltd. Dechra Pharmaceuticals plc Hester Biosciences Limited Phytobiotics Futterzusatzstoffe GmbH Merck & Co., Inc. Elanco Animal Health Incorporated Avivagen Inc. Boehringer Ingelheim International GmbH Vetoquinol SA Bayer HealthCare AG Huvepharma AD Zoetis Inc. Laboratorios Hipra S.A. Vets Plus Inc. Inovet (V.M.D. NV/sa) Delacon Biotechnik GmbH Virbac SA Bimeda Holdings plc Norbrook Laboratories Ltd. BioChek BV Neogen Corporation Anpario plc Alivira Animal Health Limited The Archer-Daniels-Midland Company Phibro Animal Health Corporation Show more
Healthcare, Market Report
06:28 04.12.2024

emerging trends shaping the future of animal healthcare market

The global animal healthcare market is set to grow significantly, projected to reach USD 5,759.3 billion by 2032, driven by increased pet ownership, rising awareness of animal health, and technological advancements. Key trends include a shift towards organic solutions, personalized care, and sustainable products, alongside a surge in demand for veterinary services and livestock health. Major players are focusing on innovation and strategic partnerships to enhance their market presence.
PharmiWeb.com
United States Dollar Boehringer Ingelheim International GmbH Elanco Animal Health Incorporated Merck & Co., Inc. Virbac Group Zoetis Inc. Bayer AG Abbott Laboratories USA DEU Show more
Healthcare, Market Report
20:01 27.11.2024

consumer healthcare market poised for rapid growth driven by digital innovations

The consumer healthcare market is projected to grow significantly, reaching $1,476.45 billion by 2028, with a CAGR of 22.1%. Key drivers include an aging population, increased reliance on OTC medications, and the rise of e-commerce. Major players like Johnson & Johnson and Sanofi are adapting to trends in digital health and personalized care solutions.
EIN News
United States Dollar Perrigo Company plc Cardinal Health, Inc. Johnson & Johnson Church & Dwight Co., Inc. Herbalife Nutrition Ltd. Nestlé S.A. Abbott Laboratories Teva Pharmaceutical Industries Ltd. AstraZeneca PLC DSM Nutritional Products AG Pfizer Inc. Colgate-Palmolive Company AbbVie Inc. Bayer AG BASF SE Glaxosmithkline plc Novartis International AG CVS Health Corporation Boehringer Ingelheim International GmbH Sanofi Amway Corporation Novo Nordisk A/S Ipsen S.A. Bristol-Myers Squibb Company McKesson Corporation Merck & Co., Inc. The Clorox Company Reckitt Benckiser Group plc Cigna Corporation Eli Lilly and Company Brian Johnson Show more
Healthcare, Market Report
00:30 27.11.2024

germany's veterinary market poised for growth with advanced care and technology

Germany's veterinary market is characterized by advanced diagnostic technologies and a high standard of care, with a projected growth rate of 5.95% from 2023 to 2033. Key players include Boehringer Ingelheim and Zoetis, while the livestock segment is expected to dominate due to its significance in the agricultural economy. The market faces challenges such as high service costs and regulatory hurdles, but increasing awareness of animal health drives demand for veterinary services.
Spherical Insights
Boehringer Ingelheim International GmbH Elanco Animal Health Incorporated IDEXX Laboratories, Inc. Zoetis Inc. Merck & Co., Inc. Phibro Animal Health Corporation Vetoquinol SA Ceva Animal Health DEU Show more
Healthcare, Market Report
17:35 18.11.2024

france veterinary healthcare market projected to grow at 3.95 percent CAGR

Investment in research and development (R&D) in veterinary healthcare in France rose by 14.2% to 5.8 billion euros. The market is projected to grow at a CAGR of 3.95% from 2023 to 2033, driven by increasing pet ownership and concerns over animal welfare, despite challenges like counterfeit medicines and rising care costs. The therapeutics segment is expected to dominate, particularly for ruminants, as the demand for effective animal health strategies intensifies following recent disease outbreaks.
Spherical Insights
Euro Elanco Merck & Co., Inc. IDEXX Laboratories, Inc. Vetoquinol SA Zoetis Inc. Boehringer Ingelheim International GmbH Ceva Animal Health, Inc. FRA Show more
Healthcare, Market Report
17:34 18.11.2024

global livestock healthcare market projected to reach 79.39 billion by 2028

The global livestock healthcare market is projected to grow from $50.74 billion in 2023 to $79.39 billion by 2028, with a CAGR of 9.6%. This growth is driven by increasing livestock populations, rising demand for animal products, and the need for effective disease prevention and management strategies. Key players include Merck, Zoetis, and Bayer, with technological advancements enhancing market dynamics.
EIN News
Elanco Animal Health Incorporated Zoetis Inc. Bayer HealthCare AG Merck & Co., Inc. Boehringer Ingelheim International GmbH CHN RUS USA JPN BRA KOR DEU GBR IND IDN AUS Bayer Healthcare AG The Archer-Daniels-Midland Company Zoetis Inc. Merck & Co Inc. Boehringer Ingelheim International GmbH Show more
Healthcare, Market Report
13:00 08.11.2024

FDA approves POLARx Cryoablation System for treating paroxysmal atrial fibrillation

The FDA has approved the POLARx Cryoablation System for treating paroxysmal atrial fibrillation. Meanwhile, Amneal Pharmaceuticals filed a New Drug Application for PEMRYDI RTU, aimed at non-squamous non-small cell lung cancer and malignant pleural mesothelioma. The global pleural diseases market is projected to grow, with thoracentesis expected to dominate treatment options, particularly in North America, driven by increasing healthcare investments and a rising geriatric population.
Spherical Insights
United States Dollar Avik Pharma Pfizer CentreOne WakeMed Health and Hospitals Boston Medical Service Pipelinepharma Sanofi Hoffmann-La Roche A Bausch Inc. Boston Scientific Corporation Max Health Amneal Pharmaceuticals, Inc. Hovione Farmaciência SA Boehringer Ingelheim International GmbH USA FRA CHN JPN ESP MEX BRA GBR DEU ARE IND ZAF ITA CAN Show more
Healthcare, Market Report
22:05 06.11.2024

global pet healthcare market projected to reach 353 billion by 2028

The global pet healthcare market is projected to grow from $239.29 billion in 2023 to $255.96 billion in 2024, with a CAGR of 7.0%. Key drivers include an increasing pet population, advancements in veterinary care, and a focus on preventive health. By 2028, the market is expected to reach $353.66 billion, driven by trends such as pet humanization and economic prosperity.
EIN News
Elanco Animal Health Incorporated Norbrook Laboratories Ltd. PETCO Animal Supplies Inc. Phibro Animal Health Corporation Royal Canin Merck & Co., Inc. VCA Animal Hospitals Inc. IDEXX Laboratories, Inc. Perrigo Company plc Chewy, Inc. Colgate-Palmolive Company Mars Inc. Trupanion, Inc. Nestlé S.A. Zoetis Inc. Sanofi Boehringer Ingelheim International GmbH Vetoquinol S.A. Ceva Sante Animale SA General Mills, Inc. USA IND AUS FRA DEU BRA IDN JPN RUS GBR KOR CHN Sanofi SA Mars Inc. General Mills Inc. Nestle SA Merck & Co Inc. Show more
Healthcare, Market Report
03:01 29.10.2024
Trending
Subcategory
Industry Trends Corporate News Startups & Entrepreneurship Retail and Consumer Goods Software Development Trends AI Innovations Emerging Startups Funding Rounds & Investments Consumer Protection Regulations Industry Mergers & Acquisitions Venture Capital Investments Economic Indicators Government Economic Policies Cybersecurity Innovations & Tech AI & Automation Regulations Fintech Startups Global Trade Developments IPOs of Tech Companies Anti-Money Laundering (AML) Regulations Cybersecurity Laws
Countries:
USA IND CHN SAU JPN ARE GBR TWN FRA TUR HKG ISR IDN RUS SGP EGY KOR PRK DEU THA
Companies:
Nvidia Corporation Microsoft Corporation Corp. Google Inc. Apple Inc. Google LLC Amazon.com Inc. Alphabet Inc. Oravel Stays Ltd. Shutterstock Inc. ProSus Aristo BIO-Tech AND Lifescience Ltd. IFL Enterprises Ltd. Imarticus Learning Ltd. Nestlé SA Patanjali Ayurved Ltd. Patanjali Foods Ltd. Temenos AG Nintendo CO. Ltd. RateGain Travel Technologies Ltd. Nazara Technologies Ltd.
Currencies:
United States Dollar Indian Rupee Chinese Yuan
People:
Donald Trump Amit Mehta Joe Biden Reem Harb Simona Suzuki Ritesh Agarwal Matt Garman Xi Jinping Faisal F. Alibrahim David McCallum Subhash Sheoratan Mundra Ashutosh Sharma Manoj Kumar Agarwal Dharshan Shanthamurthy Arjun Soin Tanmay Bhat Rahul Sethpal Arjun Ramani Advaith Vishwanath Jason Zhao

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.